IL-29/IL-28B (IFN-lambda 1/3) ELISA DY1598B-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemIL-29/IL-28B (IFN-lambda 1/3) ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY1598B-05
Quantity1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
ApplicationsELISA
Detection Range62.50 - 4000 pg/mL
ReactivityHuman
Detection TargetIL-29/IL-28B (IFN-lambda 1/3)
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) SAMD9 senses cytosolic double-stranded nucleic acids in epithelial and mesenchymal cells to induce antiviral immunityNature communicationsApril 22, 2025Hou G, Beatty W, Ren L, Ooi YS, Son J, Zhu Y, Sheng Q, Huang W, Li D, Liu C, et al.and CCL5 levels were tested with human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA kit (R&D Systems #DY1598B05) and human CCL5/RANTES DuoSet ELISA kit (R&D Systems #DY27805) according to the manufacturer’s protocol. SDS-PAGE

(2) Passage-attenuated Powassan virus LI9P protects mice from lethal LI9 challenge and links envelope residue D308 to neurovirulencemBioApril 9, 2025Himmler GE, Mladinich MC, Conde JN, Gorbunova EE, Lindner MR, Kim HK, Mackow ER.

(3) Innate immune sensing of rotavirus by intestinal epithelial cells leads to diarrheaCell Host & MicrobeMarch 12, 2025Gaopeng Hou, Juhee Son, Maria Florencia Gomez Gomez Castro, Takahiro Kawagishi, Xingxing Ren, Alexa N. Roth, Avan Antia, Qiru Zeng, Anna L. DeVeaux, Ningguo Feng, et al.assays,Critical commercial assays The human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA kit,R&D Systems,Cat# DY1598B05 Serotonin ELISA kit,IBL International,Cat# RE59121 RNeasy Plus Mini Kit,QIAGEN,Cat# 74136 High-Capacity

(4) Exploiting a type III interferon response to improve chemotherapeutic safety and efficacyEuropean Journal of Pharmaceutical SciencesJanuary 1, 2025Scott G. Tilden, Madison H. Ricco, Emily A. Hemann, Thomas J. Anchordoquythe manufacturer’s recommendations and protocols. Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet® ELISA (DY1598B-05) was purchased from R&D Systems® (Minneapolis, MN). ELISA Lower Limit of Quantification (LLoQ) = 31.30

(5) A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell modelsNature CommunicationsSeptember 27, 2024Maritza Puray-Chavez, Jenna E. Eschbach, Ming Xia, Kyle M. LaPak, Qianzi Zhou, Ria Jasuja, Jiehong Pan, Jian Xu, Zixiang Zhou, Shawn Mohammed, et al.supernatants were also subjected to an IFN-β ELISA assay (InvivoGen, #luex-hinfbv2) or IFN-λ ELISA assay (DY1598B-05 from R&D systems) following the manufacturer’s instructions. The concentration of IFNs in cell culture

(6) IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humansInfection and immunityFebruary 13, 2024De M, Sukla S, Bharatiya S, Keshri S, Roy DG, Roy S, Dutta D, Saha S, Ejazi SA, Ravichandiran V, et al.

(7) Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsNature microbiologyFebruary 1, 2024Reuschl AK, Thorne LG, Whelan MVX, Ragazzini R, Furnon W, Cowton VM, De Lorenzo G, Mesner D, Turner JLE, Dowgier G, et al.

(8) ZIKV induction of tristetraprolin in endothelial and Sertoli cells post-transcriptionally inhibits IFNβ/λ expression and promotes ZIKV persistencemBioOctober 31, 2023Schutt WR, Conde JN, Mladinich MC, Himmler GE, Mackow ER.

(9) SINE RNA of the imprinted miRNA clusters mediates constitutive type III interferon expression and antiviral protection in hemochorial placentasCell host & microbeJuly 12, 2023Wickramage I, VanWye J, Max K, Lockhart JH, Hortu I, Mong EF, Canfield J, Lamabadu Warnakulasuriya Patabendige HM, Guzeloglu-Kayisli O, Inoue K, et al.hours, the media was replaced with or without 400 ng/mL of anti-human IFNL3 antibody (R&D Systems Cat#DY1598B-05) and collected after 66 hours. mTS cells were transfected with miR-467b-5p (Life Technologies #MC11605),

(10) Transcriptomic analysis of the innate immune response to in vitro transfection of plasmid DNAMolecular Therapy - Nucleic AcidsMarch 14, 2023Eric Warga, Jared Anderson, Matthew Tucker, Emily Harris, Jacob Elmerand stored at −72°C until needed. DuoSet ELISA kits were then used to quantify IFNL1/3 (Biotechne #DY1598B-05) levels according to the manufacturer’s protocol. Statistical methods DEGs were defined as genes having

(11) Identification of novel lactic acid bacteria with enhanced protective effects against influenza virusPloS oneJanuary 1, 2023Sugimoto A, Numaguchi T, Chihama R, Takenaka Y, Sato Y.

(12) A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognitionPLoS pathogensMay 1, 2022Gibson AR, Sateriale A, Dumaine JE, Engiles JB, Pardy RD, Gullicksrud JA, O'Dea KM, Doench JG, Beiting DP, Hunter CA, et al.

(13) Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1Mucosal immunologyMay 1, 2022Stölting H, Baillon L, Frise R, Bonner K, Hewitt RJ, Molyneaux PL, Gore ML, Breathing Together Consortium, Barclay WS, Saglani S, et al.

(14) Deficiency in coatomer complex I causes aberrant activation of STING signallingNature communicationsApril 28, 2022Steiner A, Hrovat-Schaale K, Prigione I, Yu CH, Laohamonthonkul P, Harapas CR, Low RRJ, De Nardo D, Dagley LF, Mlodzianoski MJ, et al.

(15) Inhibitor of growth protein 3 epigenetically silences endogenous retroviral elements and prevents innate immune activationNucleic acids researchDecember 16, 2021Song Y, Hou G, Diep J, Ooi YS, Akopyants NS, Beverley SM, Carette JE, Greenberg HB, Ding S.

(16) Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbationClinical and translational medicineJune 1, 2021Laanesoo A, Urgard E, Periyasamy K, Laan M, Bochkov YA, Aab A, Magilnick N, Pooga M, Gern JE, Johnston SL, et al.human CXCL1/GRO alpha DuoSet ELISA (R&D Systems, DY275‐05), and human IL‐29/IL‐28B (IFN‐lambda 1/3) DuoSet ELISA kit (R&D Systems, DY1598B‐05) were used according to the manufacturers’ instructions. For BAL fluids, a mouse CXCL1/KC DuoSet ELISA

(17) SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon ResponseCellsMarch 2, 2021Oh SJ, Shin OS.

(18) Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infectionCell reportsJanuary 26, 2021Hendricks MR, Lane S, Melvin JA, Ouyang Y, Stolz DB, Williams JV, Sadovsky Y, Bomberger JM.

(19) The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cellsArthritis research & therapyJune 5, 2020Hjorton K, Hagberg N, Pucholt P, Eloranta ML, Rönnblom L.

(20) Dysbiotic oral microbiota and infected salivary glands in Sjögren's syndromePloS oneJanuary 1, 2020Alam J, Lee A, Lee J, Kwon DI, Park HK, Park JH, Jeon S, Baek K, Lee J, Park SH, et al.

Be the First to Write a Review!

IL-29/IL-28B (IFN-lambda 1/3) ELISA

IL-29/IL-28B (IFN-lambda 1/3) ELISA

IL-29/IL-28B (IFN-lambda 1/3) ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (41)

Reviews

IL-29/IL-28B (IFN-lambda 1/3) ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map